Flavonoid morin and telomerase inhibitor (MST-312) are two potential therapeutic compounds which have been found to lower tumourigenicity of CSCs by targeting signal transducer and activator of transcription 3 (STAT3) and telomerase in human colon cancer cells [104]. This evidence concerns the gene STAT3 and colonic neoplasm.